Craig Morley

Craig Morley currently serves as the Director of Business Development NA at MiRXES, where the focus is on advancing genomic and miRNA technologies for personalized healthcare solutions. Previous experience includes roles as CEO at MOgene, where Morley led genomic services for R&D in clinical and biotech fields, and Head of Commercial Operations at PRI Bio, where Craig significantly increased revenue and contract backlog in biowaste sterilization. Morley has held various leadership positions at companies such as Evans Analytical Group, Transposagen Biopharmaceuticals, and Merck KGaA, where Craig drove strategic initiatives and growth in the life sciences sector. With a strong background in global marketing and strategic development, Morley's career spans numerous roles in prestigious firms, beginning with Eli Lilly, where foundational experiences in cardiovascular marketing were established. Craig Morley holds a Bachelor of Pharmacy from the University of Health Sciences and Pharmacy in St. Louis.